Brown-Forman FY2027 Q1: sales down 1%, EPS up 6% to $0.38
Brown-Forman's fiscal 2027 first quarter was a flat-top-line quarter with better-looking profit: net sales fell 1.0% to $911 million, yet diluted EPS rose 6.0% to $0.38 on lower postretirement costs and prior-year buybacks rather than on selling more whiskey. Read the revenue and organic operating income lines as the real signal. View: Neutral.
1 · Expected vs. Actual
Free preview belowDiluted EPS rose to $0.38 from $0.36, a 6.0% gain, while net income rose only 3.0% to $176 million — the gap comes from a smaller share count after prior-year repurchases. Management attributes the increase to lower non-operating postretirement expense of $1 million versus $19 million a year ago, partly offset by operating income of $252 million, down 3.0%.
Net sales slipped 1.0% to $911 million from $924 million, and organic sales were also down 1.0%, so this is not just currency or portfolio noise. The mix tells the story: whiskey was flat at $658 million and Ready-to-Drink grew to $154 million, while tequila fell to $54 million, the rest of the portfolio dropped to $39 million after the Korbel relationship ended, and non-branded and bulk shrank to $6 million.
Log in to read 5 analyses a week for free
Create a free account to read 5 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.